Which respiratory condition is often treated with leukotriene modifiers?

Leukotriene modifiers are primarily used in the management of asthma, making it the correct choice in this scenario. These medications work by blocking the action of leukotrienes, substances in the body that contribute to inflammation, bronchoconstriction, and excessive mucus production, all of which are key features of asthma. By inhibiting these inflammatory pathways, leukotriene modifiers help to reduce asthma symptoms, prevent asthma attacks, and improve overall lung function.

In contrast, while chronic obstructive pulmonary disease (COPD) also involves inflammation of the airways, it is primarily treated with bronchodilators and corticosteroids rather than leukotriene modifiers. Pneumonia is typically addressed with antibiotics and supportive care rather than the use of leukotriene modifiers. Lastly, interstitial lung disease involves a range of disorders affecting lung tissue and is not treated with leukotriene modifiers, as the underlying pathology differs significantly from that of asthma.